Heartware slips on a bigger Q2 EPS loss

Heartware International (HTWR -7%) slips after reporting a Q2 EPS loss of $0.79 versus the estimated $0.78, missing by $0.01.

EPS were Up 51% from the same quarter last year.

Revenue came in at $50.80M, +75% Y/Y.

Revenue from international markets, generated through the sale of 288 units, was $25.7M, +4% Y/Y.

R&D costs rose nearly 25% to $24.2M, primarily due to clinical trial costs related to advancing its pipeline technologies.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs